Clopidogrel as adjunctive antiplatelet therapy during coronary stenting

Journal of the American College of Cardiology

Volumn 34, Issue 7, 1999, Pages 1884-1890

  Mishkel, Gregory J ^a   Aguirre, Frank V ^a   Ligon, Robert W ^a   Rocha Singh, Krishna J ^a   Lucore, Charles L ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; SAFETY; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0033404702     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00443-X     Document Type: Article

References (23)

1. Mak K.H., Belli G., Ellis S.G., Moliterno D.J. Subacute stent thrombosis evolving issues and current concepts . J Am Coll Cardiol. 27:1996;494-503.
2. Bittl J.A. Advances in coronary angioplasty. N Engl J Med. 335:1996;1290-1302.
3. Serruys P.W., de Jaegere P., Kiemeneji F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
4. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
5. Verstraete M., Zoldhelyi P. Novel antiplatelet drugs in development. Drugs. 49:1995;856-884.
6. Schafer A.I. Antiplatelet therapy. Am J Med. 101:1996;199-209.
7. Bennet C.L., Weinberg P.D., Rozenberg-Ben-Dror K., et al. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 128:1998;541-544.
8. Steinhubl S.R., Tan W.A., Foody J.M., et al. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. JAMA. 281:1999;806-810.
9. A randomized, blinded trial of Clopidogrel versus Aspirin in Patients at Risk of Ischemic Event (CAPRIE). Lancet. 348:1996;1329-1339.
10. Sharis P.J., Cannon C.P., Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med. 129:1998;394-405.
11. Schömig A., Neumann F.-J., Kastrati A., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 334:1996;1084-1089.
12. Bertrand M.E., Legrand V., Boland J., et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation. 98:1996;1597-1603.
13. Leon M.B., Baim D.S., Popma J.J., et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med. 339:1998;1665-1671.
14. Urban P., Macaya C., Rupprecht H.-J., et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. The Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS). Circulation. 98:1998;2126-2132.
15. Albiero R., Hall P., Itoh A., et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation. 95:1997;1145-1156.
16. Moussa I., Oetgen M., Roubin G., et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation. 99:1999;2364-2366.
17. Jauhar R, Savino S, Deutsch E, et al. Aspirin and clopidogrel combination therapy in coronary stenting: a prospective registry (abstr). Am J Cardiol 1998;82(7A):TCT-262.
18. Berger P., Bellot V., Melby S., et al. Clopidogrel versus ticlopidine for coronary stents (abstr). J Am Coll Cardiol. 33:(Suppl A):1999;34A.
19. Makkar R.R., Eigler N.L., Kaul S., et al. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis. Eur Heart J. 19:1998;1538-1546.
20. Harker L.A., Marzec U.M., Kelly A.B., et al. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation. 98:1998;2461-2469.
21. Gregorini L., Marco J., Fajedet J., et al. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilatation procedures. J Am Coll Cardiol. 29:1997;13-20.
22. Van de Loo A., Nauck M., Noory E., et al. Enhancement of platelet inhibition of ticlopidine plus aspirin versus aspirin alone given prior to elective PTCA. Eur Heart J. 19:1998;96-102.
23. Randomised placebo-controlled and balloon-angioplasty trial to assess safety of coronary stenting with the use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 352:1998;87-92.